Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | FABP3 | P05413 | 9/20 | 0.45 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.40 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1121644 | 1.00 | CA1 (0.46) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL3930736 | 1.00 | CA1 (0.46) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL640842 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL11011436 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL5575143 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL23174700 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL10825634 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL21384974 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| Silver SCHEMBL21899896 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 | |
| SCHEMBL22439765 | 0.98 | CA1 (0.44) | CA1FABP3FFAR3HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2954951-B1 | Carrier catalyst and method for producing a porous graphitised carbon material coated with metal nanoparticles | HERAEUS DEUTSCHLAND GMBH & CO KG (DE) | 2023-08-02 | — | — | EP | disclosed |
| CN-106457214-B | Catalyst support and method for producing porous graphitized carbon material covered with metal nanoparticles | 贺利氏德国有限及两合公司 | 2020-07-24 | — | — | CN | disclosed |
| US-10283779-B2 | Catalyst support and method for producing porous graphitized carbon material covered with metal nanoparticles | Heraeus Deutschland GmbH & Co. KG (DE) | 2019-05-07 | — | — | US | disclosed |
| WO-2018189588-A1 | MICROCAPSULES HAVING METALLIC NANOPARTICLES, METHODS FOR MAKING MICROCAPSULES HAVING METALLIC NANOPARTICLES, AND USES THEREOF | RHODIA OPERATIONS (FR) | 2018-10-18 | — | — | WO | disclosed |
| US-20170246690-A1 | STABILIZING AGENT-FREE METAL NANOPARTICLE SYNTHESIS AND USES OF METAL NANOPARTICLES SYNTHESIZED THEREFROM | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2017-08-31 | — | — | US | disclosed |
| US-20170141405-A1 | CATALYST SUPPORT AND METHOD FOR PRODUCING POROUS GRAPHITIZIED CARBON MATERIAL COVERED WITH METAL NANOPARTICLES | Heraeus Deutschland GmbH & Co. KG (DE) | 2017-05-18 | — | — | US | disclosed |
| EP-3157697-A1 | STABILIZING AGENT-FREE METAL NANOPARTICLE SYNTHESIS AND USES OF METAL NANOPARTICLES SYNTHESIZED THEREFROM | Rhodia Operations (FR) | 2017-04-26 | — | — | EP | disclosed |
| US-20140179958-A1 | CATALYSTS AND PROCESSES FOR PRODUCING BUTANOL | CELANESE INTERNATIONAL CORPORATION (US) | 2014-06-26 | — | — | US | disclosed |
| US-8597397-B2 | Production of metal nanoparticles | CABOT CORPORATION (US) | 2013-12-03 | — | — | US | disclosed |
| US-8318255-B2 | Adherends with enhanced surfaces | THE BOEING COMPANY (US) | 2012-11-27 | — | — | US | disclosed |
| US-20070034052-A1 | rapid mixing a solution of a metal compound ( e.g AgNO3 ) that is capable of being reduced to a Ag by a polyol( ethyelne glycol decomposed to acetaldehyde which acts as reducing agent), with a heated solution containing above polyol and a polypyrrolidone capable of being adsorbed on the nanoparticles | CABOT CORPORATION (US) | 2007-02-15 | — | — | US | disclosed |
| WO-2006076612-A2 | A PROCESS FOR MANUFACTURING APPLICATION SPECIFIC PRINTABLE CIRCUITS (ASPC’S) AND OTHER CUSTOM ELECTRONIC DEVICES | CABOT CORPORATION (US) | 2006-07-20 | — | — | WO | disclosed |
| WO-2006076611-A2 | PRODUCTION OF METAL NANOPARTICLES | CABOT CORPORATION (US) | 2006-07-20 | — | — | WO | disclosed |
| US-20060159603-A1 | Separation of metal nanoparticles | CABOT CORPORATION (US) | 2006-07-20 | — | — | US | disclosed |
| EP-0356332-B1 | Platinum complexes of single isomer neoalkyl acids | LIPOSOME CO INC (US) | 1994-05-25 | — | — | EP | disclosed |
| EP-0514525-A1 | PREPARATION OF PLATINUM GROUP METAL AND RHENIUM CARBOXYLATES | MOONEY CHEMICALS, INC. (US) | 1992-11-25 | — | — | EP | disclosed |
| US-5149854-A | PREPARATION OF PLATINUM GROUP METAL AND RHENIUM CARBOXYLATES | MOONEY CHEMICALS, INC. (US) | 1992-09-22 | — | — | US | disclosed |
| WO-1992010460-A1 | PREPARATION OF PLATINUM GROUP METAL AND RHENIUM CARBOXYLATES | MOONEY CHEMICALS, INC. (US) | 1992-06-25 | — | — | WO | disclosed |
| WO-1990002111-A1 | PLATINUM COMPLEXES OF SINGLE ISOMER NEOALKYL ACIDS | THE LIPOSOME COMPANY, INC. (US) | 1990-03-08 | — | — | WO | disclosed |
| EP-0356332-A2 | Platinum complexes of single isomer neoalkyl acids | THE LIPOSOME COMPANY, INC. (US) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179958-A1 | CATALYSTS AND PROCESSES FOR PRODUCING BUTANOL | ADH1C, ADH1A, ADH5 | CA1 100/4885FABP3 4749/4885FFAR3 4010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.